Redcare Pharmacy NV (ETR:RDC)

Market Cap	1.24B -21.7%
Revenue (ttm)	3.22B +20.2%
Net Income	-42.00M
EPS	-2.09
Shares Out	20.58M
PE Ratio	n/a
Forward PE	139.98
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,149
Open	60.00
Previous Close	59.45
Day's Range	58.70 - 62.25
52-Week Range	30.20 - 90.10
Beta	1.42
Analysts	Buy
Price Target	87.50 (+44.63%)
Earnings Date	Oct 29, 2026

About Redcare Pharmacy NV

Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is based in Sevenum, the Netherlands.

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2001
• Employees: 2,163
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: RDC

Financial Performance

In 2025, Redcare Pharmacy NV's revenue was 2.94 billion, an increase of 24.06% compared to the previous year's 2.37 billion. Losses were -37.70 million, -17.14% less than in 2024.

Analyst Summary

According to 10 analysts, the average rating for RDC stock is "Buy." The 12-month stock price target is €87.50, which is an increase of 44.63% from the latest price.

Price Target

€87.50

(44.63% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 25, 2026

Data Sources Report a data error